rct
2010
High Quality
Effects of medical therapies on retinopathy progression in type 2 diabetes: the ACCORD Eye Study
ACCORD Study Group, ACCORD Eye Study Group, Chew EY, Ambrosius WT, Davis MD, Danis RP, et al.
Published in New England Journal of Medicine, Vol. 363 (3), pp. 233-44
Methodology
Randomised factorial trial of intensive glycaemic, lipid and blood pressure control with 4-year retinopathy imaging endpoints.
Key Findings
Intensive glycaemic control and fenofibrate-statin therapy slowed retinopathy progression; blood pressure lowering did not.
Conclusions
Blood glucose control, not blood pressure lowering, protects diabetic vision.
Limitations
Type 2 diabetes only; no supplement arms.
Related Health Concerns
Study Details
Year:2010
Sample Size:2,856
Quality Score:9/10
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.